Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Mayne Pharma Group ( (AU:MYX) ) is now available.
Mayne Pharma Group has announced that First Sentier Investors (Australia) IM Ltd has ceased to be a substantial holder in the company as of September 23, 2025. This change in substantial holding could impact the company’s shareholder structure and influence its market perception, as substantial holders often play a significant role in corporate governance and strategic decisions.
The most recent analyst rating on (AU:MYX) stock is a Buy with a A$6.10 price target. To see the full list of analyst forecasts on Mayne Pharma Group stock, see the AU:MYX Stock Forecast page.
More about Mayne Pharma Group
Average Trading Volume: 277,801
Technical Sentiment Signal: Sell
Current Market Cap: A$406.2M
Find detailed analytics on MYX stock on TipRanks’ Stock Analysis page.